Antion Biosciences

Marco Alessandrini, Ph.D., CEO 

April 11 | 9:45am | Salone dei Cavalieri, Section 2 

Geneva, Switzerland 


Antion Biosciences SA is a Swiss-based biotechnology company developing universal cell and gene therapy products for the treatment of diseases with significant unmet medical needs. Antion’s proprietary gene silencing and co-expression gene constructs allow for a modular and tunable approach to multiplex engineering of therapeutic cells. By developing off-the-shelf therapies with enhanced potency, our vision is to make cell and gene therapies universal and broaden access to these life-changing therapies for all patients. 

By using this website you agree to accept our Privacy Policy and Terms & Conditions